Clinical

1 shares

Depression is approximately five times more prevalent in patients with sickle cell disease (SCD) than in the general...

share

Preliminary data from the ongoing TRANSCEND trial showed that patients with relapsed or refractory diffuse large B-cell lymphoma...

share

While treatment with CD19-directed chimeric antigen receptor (CAR) T cells has demonstrated impressive response rates of over 80%...

share

Data from two patients in an ongoing phase I/II clinical trial of LentiGlobin BB305, a gene therapy for...

share

Impel NeuroPharma announced that the first patient was dosed in the recently-initiated Phase 1 clinical trial of INP104...

share

Otsuka Pharmaceutical and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 clinical trials...

share

Flex Pharma announced that, under its open investigational new drug (IND) application, the Company has initiated a Phase...

share

Ortek Therapeutics announced that the Ortek ECD™ received 510(k) clearance from the U.S. Food and Drug Administration. The ECD...